WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities. More Details
Adequate balance sheet and slightly overvalued.
Share Price & News
How has WELL Health Technologies's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: WLYY.F's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: WLYY.F exceeded the US Healthcare industry which returned 15.9% over the past year.
Return vs Market: WLYY.F exceeded the US Market which returned 13.6% over the past year.
Price Volatility Vs. Market
How volatile is WELL Health Technologies's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is WELL Health Technologies undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: WLYY.F ($5.2) is trading below our estimate of fair value ($8.22)
Significantly Below Fair Value: WLYY.F is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: WLYY.F is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.
PE vs Market: WLYY.F is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate WLYY.F's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: WLYY.F is overvalued based on its PB Ratio (17.1x) compared to the US Healthcare industry average (2.9x).
How is WELL Health Technologies forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: WLYY.F is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: WLYY.F is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: WLYY.F is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: WLYY.F's revenue (34.1% per year) is forecast to grow faster than the US market (9.7% per year).
High Growth Revenue: WLYY.F's revenue (34.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if WLYY.F's Return on Equity is forecast to be high in 3 years time
How has WELL Health Technologies performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: WLYY.F is currently unprofitable.
Growing Profit Margin: WLYY.F is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: WLYY.F is unprofitable, and losses have increased over the past 5 years at a rate of 60.9% per year.
Accelerating Growth: Unable to compare WLYY.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: WLYY.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (31.1%).
Return on Equity
High ROE: WLYY.F has a negative Return on Equity (-18.86%), as it is currently unprofitable.
How is WELL Health Technologies's financial position?
Financial Position Analysis
Short Term Liabilities: WLYY.F's short term assets (CA$28.9M) exceed its short term liabilities (CA$10.8M).
Long Term Liabilities: WLYY.F's short term assets (CA$28.9M) exceed its long term liabilities (CA$25.6M).
Debt to Equity History and Analysis
Debt Level: WLYY.F's debt to equity ratio (21.5%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if WLYY.F's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: WLYY.F has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if WLYY.F has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is WELL Health Technologies's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate WLYY.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate WLYY.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if WLYY.F's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if WLYY.F's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of WLYY.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Hamed Shahbazi (45 yo)
Mr. Hamed Shahbazi, B.Sc serves as a Director at Hire Technologies Inc. (formerly known as Bay Talent Group Inc.) (formerly known as Danacore Industries Inc.). He is Founder of WELL Health Technologies Cor ...
|Founder||2.33yrs||no data||9.21% |
|Chief Financial Officer||1.42yrs||CA$103.33k||0.58% |
|Chief Operating Officer||1.67yrs||CA$39.39k||2.14% |
|Senior Vice President of Corporate Development||1.42yrs||CA$216.00k||no data|
|Chief Information Officer||1.17yrs||no data||2.15% |
|VP of Corporate Strategy & Investor Relations||1.42yrs||no data||no data|
|Senior Vice President of Strategic Partnerships & Marketing||1.67yrs||no data||no data|
|HR & Office Manager||1.67yrs||no data||no data|
|Chief Medical Officer||1.83yrs||no data||no data|
|Senior Vice President of Product Development||1.67yrs||no data||no data|
|Head of Acquisitions - Eastern Canada||0.17yr||no data||no data|
Experienced Management: WLYY.F's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
|Founder||2.33yrs||no data||9.21% |
|Independent Director||2.42yrs||no data||0.33% |
|Independent Director||4.5yrs||no data||0.11% |
|Independent Director||2.58yrs||no data||0.44% |
|Member of Advisory Board||1yr||no data||no data|
|Independent Director||0.42yr||no data||no data|
Experienced Board: WLYY.F's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35.8%.
WELL Health Technologies Corp.'s company bio, employee growth, exchange listings and data sources
- Name: WELL Health Technologies Corp.
- Ticker: WLYY.F
- Exchange: OTCPK
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: CA$918.162m
- Listing Market Cap: CA$697.114m
- Shares outstanding: 132.87m
- Website: https://www.well.company
Number of Employees
- WELL Health Technologies Corp.
- 322 Water Street
- Suite 200
- British Columbia
- V6B 1B6
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|WELL||TSX (The Toronto Stock Exchange)||Yes||Common Shares||CA||CAD||Jun 2017|
|W7V||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Jun 2017|
|WLYY.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Jun 2017|
WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities. The company also provides digital electronic medical records (EMR) software services; and telehealth services. ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/19 05:49|
|End of Day Share Price||2020/09/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.